These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8602312)
41. Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial. Mai Q; Hu X; Yang G; Luo Y; Huang K; Yuan Y; Zhou C Am J Obstet Gynecol; 2017 Jan; 216(1):42.e1-42.e10. PubMed ID: 27555316 [TBL] [Abstract][Full Text] [Related]
42. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Agrawal R; Conway G; Sladkevicius P; Tan SL; Engmann L; Payne N; Bekir J; Campbell S; Jacobs H Fertil Steril; 1998 Oct; 70(4):651-8. PubMed ID: 9797093 [TBL] [Abstract][Full Text] [Related]
43. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240 [TBL] [Abstract][Full Text] [Related]
44. The Role of Interleukin-18 in Serum and Follicular Fluid during In Vitro Fertilization and Intracytoplasmic Sperm Injection. Günther V; Alkatout I; Fuhs C; Salmassi A; Mettler L; Hedderich J; Maass N; Elessawy M; Schmutzler AG; Eckmann-Scholz C Biomed Res Int; 2016; 2016():6379850. PubMed ID: 27747236 [TBL] [Abstract][Full Text] [Related]
45. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer. Gastl G; Plante M; Finstad CL; Wong GY; Federici MG; Bander NH; Rubin SC Br J Haematol; 1993 Mar; 83(3):433-41. PubMed ID: 8485049 [TBL] [Abstract][Full Text] [Related]
46. [Association between renin activity, angiotensin II and ovarian hyperstimulation syndrome]. Fan Y; Chen G Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):647-50. PubMed ID: 11930686 [TBL] [Abstract][Full Text] [Related]
47. High rate of aneuploidy in luteinized granulosa cells obtained from follicular fluid in women who underwent controlled ovarian hyperstimulation. Kaleli S; Yanikkaya-Demirel G; Erel CT; Senturk LM; Topçuoğlu A; Irez T Fertil Steril; 2005 Sep; 84(3):802-4. PubMed ID: 16169431 [TBL] [Abstract][Full Text] [Related]
48. Interleukin-2 Production by Cultured Human Granulosa Cells. Orvieto R; Dratviman-Storobinsky O; Cohen Y Am J Reprod Immunol; 2015 Nov; 74(5):392-7. PubMed ID: 26219920 [TBL] [Abstract][Full Text] [Related]
50. The role of enalapril in the prevention of ovarian hyperstimulation syndrome: a rabbit model. Gul TG; Posaci C; Caliskan S Hum Reprod; 2001 Nov; 16(11):2253-7. PubMed ID: 11679499 [TBL] [Abstract][Full Text] [Related]
51. Repeated aspiration of ovarian follicles and early corpus luteum cysts in an in-vitro fertilization programme reduces the risk of ovarian hyperstimulation syndrome in high responders. Amit A; Yaron Y; Yovel I; Peyser MR; David MP; Botchan A; Lessing JB Hum Reprod; 1993 Aug; 8(8):1184-6. PubMed ID: 8408514 [TBL] [Abstract][Full Text] [Related]
52. The human preovulatory follicle is a source of the chemotactic cytokine interleukin-8. Runesson E; Boström EK; Janson PO; Brännström M Mol Hum Reprod; 1996 Apr; 2(4):245-50. PubMed ID: 9238687 [TBL] [Abstract][Full Text] [Related]
53. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. Mastorakos G; Scopa CD; Vryonidou A; Friedman TC; Kattis D; Phenekos C; Merino MJ; Chrousos GP J Clin Endocrinol Metab; 1994 Oct; 79(4):1191-7. PubMed ID: 7525629 [TBL] [Abstract][Full Text] [Related]
54. Soluble endothelial and platelet selectins in serum and ascitic fluid of women with ovarian hyperstimulation syndrome. Daniel Y; Geva E; Amit A; Eshed-Englender T; Bar-Am A; Lessing JB Am J Reprod Immunol; 2001 Mar; 45(3):154-60. PubMed ID: 11270640 [TBL] [Abstract][Full Text] [Related]
55. Differential expression of T-helper cytokines in the peritoneal fluid of women with normal ovarian cycle compared with women with chronic anovulation. Omu AE; Al-Azemi MK; Makhseed M; Al-Oattan F; Ismail AA; Al-Tahir S; Al-Busiri N Acta Obstet Gynecol Scand; 2003 Jul; 82(7):603-9. PubMed ID: 12790840 [TBL] [Abstract][Full Text] [Related]
56. In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome. Di Pietro M; Pascuali N; Scotti L; Irusta G; Bas D; May M; Tesone M; Abramovich D; Parborell F Mol Hum Reprod; 2017 Jun; 23(6):417-427. PubMed ID: 28379469 [TBL] [Abstract][Full Text] [Related]
57. Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study. Egbase PE; Sharhan MA; Grudzinskas JG Hum Reprod; 1999 Jun; 14(6):1421-5. PubMed ID: 10357951 [TBL] [Abstract][Full Text] [Related]
58. Relationships of serum pro-inflammatory cytokines and vascular endothelial growth factor with liver dysfunction in severe ovarian hyperstimulation syndrome. Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS Hum Reprod; 2000 Jan; 15(1):66-71. PubMed ID: 10611190 [TBL] [Abstract][Full Text] [Related]
59. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome. Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945 [TBL] [Abstract][Full Text] [Related]
60. The Dual Role of PEDF in the Pathogenesis of OHSS: Negating Both Angiogenic and Inflammatory Pathways. Miller I; Chuderland D; Grossman H; Ron-El R; Ben-Ami I; Shalgi R J Clin Endocrinol Metab; 2016 Dec; 101(12):4699-4709. PubMed ID: 27680872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]